Opus Genetics, Inc.

IRD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-3 Jun 5, 2026 S-3
SCHEDULE 13D/A May 20, 2026
4 May 20, 2026 PRIMARY DOCUMENT
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G May 15, 2026
SCHEDULE 13G/A May 15, 2026
S-8 May 14, 2026 S-8
SCHEDULE 13G/A May 13, 2026
SCHEDULE 13G May 13, 2026
10-Q May 12, 2026 10-Q
8-K May 12, 2026 8-K
4 Apr 27, 2026 FORM 4
4 Apr 27, 2026 FORM 4
4 Apr 27, 2026 FORM 4
4 Apr 27, 2026 FORM 4
4 Apr 27, 2026 FORM 4
4 Apr 27, 2026 FORM 4
8-K Apr 24, 2026 8-K
144 Apr 23, 2026
144 Apr 23, 2026
144 Apr 23, 2026
144 Apr 23, 2026
144 Apr 23, 2026
EFFECT Apr 22, 2026
← Newer Page 3 of 43 · 1075 filings Older →